Neumora gets Nasdaq bid-price notice; 180 days to regain $1.00 compliance by April 26, 2027

Neumora Therapeutics, Inc.

Nasdaq notified Neumora on October 26, 2026 that its common stock is below the $1.00 minimum bid price under Listing Rule 5450(a)(1).
Company has until April 26, 2027; shares must close at or above $1.00 for at least 10 consecutive business days to cure.
If not cured, Neumora could apply to transfer to the Nasdaq Capital Market for additional time, subject to other listing standards and a fee.
Neumora said it will monitor its bid price and consider options including a reverse stock split; no assurance of compliance was given.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.